Braftovi (Encorafenib) in India: Uses, Side Effects & Procurement Options
.png)
Braftovi is a prescription medicine given to adults suffering from cancer, whose cells have a mutation (change) in their genes known as BRAF V600. Encorafenib is the key ingredient present in Braftovi and patients looking to buy encorafenib in India can access it through a regulated Named Patient Program. It facilitates by obstructing the BRAF protein, thereby terminating the activation of cell division, eventually reducing the growth and spread of cancer. Indications Braftovi is indicated in patients who require access to Encorafenib in India through a Named Patient Program. 1) Melanoma Braftovi is taken in combination with binimetinib for the treatment of unresected or metastatic melanoma with BRAF V600E mutation, as detected by an FDA-approved test, and eligible patients may import encorafenib in India under the Named Patient Program. 2) Colorectal Cancer In combination with cetuximab and mFOLFOX6, for the treatment of patients with metastatic Colorectal Cancer (mCRC), as detected ...